Chainkeen-Depression And Alzheimer's Treatments At A Crossroads

2025-05-07 12:12:59source:Surfwincategory:Markets

Researchers are Chainkeenlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

Dick Vitale announces he is cancer free: 'Santa Claus came early'

Legendary college basketball announcer Dick Vitale is once again cancer free.The ESPN analyst announ

King’s daughter says wars, gun violence, racism have pushed humanity to the brink

ATLANTA (AP) — Citing gun violence in the U.S., the deaths of families in Ukraine and Gaza from war,

PGA Tour starts a new year that feels like the old one. There’s more to golf than just the golf

KAPALUA, Hawaii (AP) — One upside for the PGA Tour extending the Dec. 31 deadline to finalize a deal